Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Niels M R van der SangenJaouad AzzahhafiDean R P P Chan Pin YinSenna RayhiVictoria M van WeedeRonald J WalhoutMelvyn Tjon Joe GinRon PistersDeborah M NicastiaJorina LangerveldGeorgios J VlachojannisRutger J van BommelYolande AppelmanJosé P S HenriquesJurriën Ten BergWouter Kikkert

Published in: Open heart (2023)

Ischaemic and bleeding events remain prevalent and are independently associated with lower QoL at 12 months follow-up in patients previously admitted for ACS. The incidence and impact of these adverse events should be considered when balancing individual ischaemic and bleeding risks.

Keyphrases

atrial fibrillation
acute coronary syndrome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
risk factors
peritoneal dialysis
risk assessment
human health